Published in
Springer, Breast Cancer Research and Treatment, 1(171), p. 43-52, 2018
DOI: 10.1007/s10549-018-4815-x
Links
Tools
The histone deacetylase inhibitor OBP-801 and eribulin synergistically inhibit the growth of triple-negative breast cancer cells with the suppression of survivin, Bcl-xL, and the MAPK pathway
Journal article published in 2018 by
Hisako Ono,
Yoshihiro Sowa 
,
Mano Horinaka,
Yosuke Iizumi,
Motoki Watanabe ,
Mie Morita,
Emi Nishimoto,
Tetsuya Taguchi,
Toshiyuki Sakai
,
Mano Horinaka,
Yosuke Iizumi,
Motoki Watanabe ,
Mie Morita,
Emi Nishimoto,
Tetsuya Taguchi,
Toshiyuki Sakai
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 